3 New Strong Buy Ratings from Top-Rated Analysts: 08/19/2025
Need some stock ideas today? Here are some recent highlights from our most-visited screener:
- Why analysts are confident Eli Lilly (LLY) still has room to grow
- Utility-scale solar projects are in demand — and it’s benefiting Array Technologies (ARRY)
- Kontoor Brands (KTB) gets a noteworthy price target increase from a top-rated analyst
P.S. Get more alerts like this daily … Try WallStreetZen Premium.
A note from our sponsors...
Buffett's $114 Secret In 1943, a teenage Warren Buffett put $114 into a special type of account called "The 29% Account." Today, that single, $114 investment would be worth over $15 million. Your bank never told you about this. Click Here to See How It Works1. Array Technologies (NASDAQ: ARRY)
Based in New Mexico, Array Technologies is a leading provider of solar tracking systems that help maximize the efficiency of utility-scale solar projects. Wall Street analysts are quite bullish on ARRY, particularly after the company delivered a double beat in its latest quarterly report. The business enjoys a strong balance sheet, and the Treasury Department’s recent decision to largely preserve tax credits for renewable projects presents a bullish medium-term catalyst.
Zen Rating: A (Strong Buy) — see full analysis >
Recent Price: $7.62 — get current quote >
Max 1-year forecast: $13.00
Why we’re watching:
- At present, 13 Wall Street analysts issue ratings for Array Technologies stock. Their coverage is split between 7 Strong Buy ratings, 1 Buy rating, and 5 Hold ratings. See the ratings
- Moreover, the average 12-month price forecast for ARRY shares, currently pegged at $9.19, implies a hefty 20.63% upside.
- UBS researcher Jon Windham maintained a Strong Buy rating on Array Technologies stock after the company reported its Q2 2025 earnings, and increased his price target from $8.50 to $9.
- Looking ahead, Windham noted that management's FY 2025 guidance suggests better gross margins in 2H than in 1H.
- Our proprietary quant rating system uses 115 factors to evaluate stocks. It keeps track of roughly 4,600 equities — and ARRY ranks in the top 3%, giving it a Zen Rating of A, which has historically corresponded to an average annualized return of 32.52%.
- Each Zen Rating is a composite score of seven Component Grade ratings. For instance, Array Technologies ranks in the top 21% when it comes to Sentiment.
- In terms of Financnials, ARRY ranks in the 82nd percentile of the equities that we track.
- However, Growth is Array Technologies’ strongest suit — in this category, the stock ranks in the top 1%. (See all 7 Zen Component Grades here >)
2. Eli Lilly (NYSE: LLY)
Eli Lilly is a bona fide pharma powerhouse. As one of the primary beneficiaries of the weight loss drug boom, the company has seen a significant increase in stock price — and although recent news surrounding an oral product fell short of expectations, Wall Street remains confident that there’s plenty of room for LLY to rally further.
Zen Rating: B (Buy) — see full analysis >
Recent Price: $701.23 — get current quote >
Max 1-year forecast: $1,135.00
Why we’re watching:
- Analyst coverage of LLY is both broad and almost unanimously positive — the stock currently has 8 Strong Buy ratings and 1 Sell rating. See the ratings
- In addition, the average price target for Eli Lilly shares, currently at $935.33, implies a hefty 33.38% upside.
- Carter Gould of Cantor Fitzgerald (a top 15% rated analyst) reiterated a Strong Buy rating on the stock after the company reported its Q2 2025 earnings on 2025/08/07, but cut his price forecast from $975 to $825.
- Gould said the launch-related "show-me-story" the company is facing was caused by orforglipron Phase 3 obesity data that fell short of expectations and semaglutide benchmarks.
- A "resolution" might not come until late 2026, the analyst said.
- LLY is currently the 4th highest-rated stock in the General Drug Manufacturer industry, which has an Industry Rating of A.
- Eli Lilly shares rank in the top 6% of the equities that we track, giving them a Zen Rating of B, which has historically corresponded to an average annualized return of 19.88%.
- LLY offers a very compelling mix of both Value and Growth— in terms of the former, it ranks in the top 18% of stocks, and in terms of the latter, it ranks in the top 13%.
- To boot, the pharma giant’s strong balance sheet has allowed it to rank in the 84th percentile when it comes to Financials.
- With all of that said, Sentiment is Eli Lilly’s strongest Component Grade rating — as it ranks in the top 10% in this category. (See all 7 Zen Component Grades here >)
A note from our sponsors...
Buffett's $114 Secret In 1943, a teenage Warren Buffett put $114 into a special type of account called "The 29% Account." Today, that single, $114 investment would be worth over $15 million. Your bank never told you about this. Click Here to See How It Works3. Kontoor Brands (NYSE: KTB)
Kontoor Brands owns not one, but two flagship denim labels — Wrangler and Lee. Even though recent trade disputes have had an effect on the company’s business, it still managed to deliver a double beat in Q2 of 2025. The company’s disciplined inventory management, focus on direct-to-consumer (DTC) channels, and growing popularity overseas provide solid growth prospects that are increasingly being recognized by Wall Street.
Zen Rating: A (Strong Buy) — see full analysis >
Recent Price: $70.90 — get current quote >
Max 1-year forecast: $99.00
Why we’re watching:
- At present, Kontoor Brands shares have 4 Strong Buy ratings and 1 Hold rating. See the ratings
- The average 12-month price forecast for KTB stock, currently at $87.60, implies a significant 23.55% upside.,
- UBS researcher Jay Sole (a top 4% rated analyst) doubled down on a Strong Buy rating on KTB after Kontoor Brands reported its Q2 2025 earnings. The analyst also increased his price target from $92 to a Street-high $99.
- Looking ahead, Sole opined that tariffs notwithstanding, Kontoor Brands' growth prospects remain strong, supported by "resilient" margins.
- Kontoor Brands is the 2nd highest-rated stock in the Apparel Manufacturing industry, which has an Industry Rating of B.
- KTB shares rank in the top 5% of the equities that we track based on a holistic analysis of 115 proprietary factors, giving them a Zen Rating of A.
- Kontoor Brands ranks in the top 16% of stocks when it comes to Financials.
- KTB also ranks in the top 12% of equities according to Value, as it is currently trading at a very attractive price to earnings (P/E) ratio of 15.69x.
- Finally, we have KTB’s strongest Component Grade rating — Artificial Intelligence. In this category, the stock ranks in the top 10%. This means that a neural network trained on two decades of market data has selected it as a likely outperformer. (See all 7 Zen Component Grades here >)
What to Do Next?
Want to get in touch? Email us at news@wallstreetzen.com.
Keep Reading
See All News
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.